Antiplatelet Activity of Coumarins: In Vitro Assays on COX-1
Atherosclerotic cardiovascular disease is the leading cause of death in developed countries. Therefore, there is an increasing interest in developing new potent and safe antiplatelet agents. Coumarins are a family of polyphenolic compounds with several pharmacological activities, including platelet...
Main Authors: | Cristina Zaragozá, Francisco Zaragozá, Irene Gayo-Abeleira, Lucinda Villaescusa |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/26/10/3036 |
Similar Items
-
Flavonoids: Antiplatelet Effect as Inhibitors of COX-1
by: Cristina Zaragozá, et al.
Published: (2022-02-01) -
INDIVIDUAL ANTIPLATELET THERAPY IN PATIENTS WITH ATHEROSCLEROSIS OF LOWER EXTREMITIES: MYTH OR REALITY?
by: O. V. Sirotkina, et al.
Published: (2018-01-01) -
Synergy, Additivity and Antagonism between Esculetin and Six Commonly Used Chemotherapeutics in Various Malignant Melanoma Cell Lines—An Isobolographic Analysis
by: Paula Wróblewska-Łuczka, et al.
Published: (2023-05-01) -
(<i>E</i>)-6-Hydroxy-2-oxo-2<i>H</i>-chromen-7-yl 3-(4-hydroxy-3-methoxyphenyl)acrylate
by: Yang-Heon Song
Published: (2023-06-01) -
Why Me? To Be an Ultra-Responder to Antiplatelet Therapy: A Case Report
by: Francesca Rosafio, et al.
Published: (2021-08-01)